Get it on Google Play

Veltassa Black Box Warning Removed

November 28, 2016 5:57 AM EST

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Galenica Group today announced that Relypsa, Inc., a Vifor Pharma Company, has received approval from the US Food and Drug Administration (FDA) for a supplemental New Drug Application (sNDA) with important updates to the US label of Veltassa (patiromer) for oral suspension. The US label for Veltassa no longer includes a Boxed Warning regarding the separation of Veltassa and other oral medications.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

FDA

Add Your Comment